Description

N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Leu-L-Dab-L-Dab-L-Leu-] is a complex, cyclic lipopeptide compound of significant interest in advanced pharmaceutical research and development. This molecule matters for its potential role as a key intermediate or active pharmaceutical ingredient (API) in novel therapeutic agents, particularly in areas requiring sophisticated peptide chemistry. It is primarily needed by research institutions, biotechnology firms, and pharmaceutical companies engaged in the synthesis of peptide-based drugs, antimicrobial agents, and other specialized bioactive compounds. The compound is identified by CAS No. 71029-32-8.

Application

This specialized cyclic lipopeptide serves critical functions in high-value research and manufacturing sectors:

• Pharmaceutical Intermediate: Acts as a crucial building block in the multi-step synthesis of complex peptide-based Active Pharmaceutical Ingredients (APIs).
• Antimicrobial Research: Serves as a lead compound or model structure in the development of new antibiotic and antifungal agents, leveraging its lipopeptide architecture.
• Bioconjugation & Drug Delivery: Utilized in research for creating peptide-drug conjugates or targeted delivery systems due to its functional groups.
• Biochemical Research: Employed as a standard or probe in studies of peptide-protein interactions, membrane permeability, and structure-activity relationships (SAR).
• Process Development & Scale-Up: Used in optimizing synthetic routes and purification processes for complex peptide manufacturing under cGMP conditions.

Basic Information

Product Name	N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Leu-L-Dab-L-Dab-L-Leu-]
CAS No.	71029-32-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Cyclic Lipopeptide 71029-32-8; [Cyclo(L-Dab-L-Dab-D-Leu-L-Leu-L-Dab-L-Dab-L-Leu), N2-[N2-(3-hydroxy-9-methyl-1-oxodecyl)-D-Dab-]-]; Lipopeptide Antibiotic Intermediate; Complex Cyclic Peptide; Dab/Leu Cyclic Peptide Derivative; Antimicrobial Lipopeptide Analog; Pharmaceutical Peptide Building Block
EINECS	Contact for details

Quality Control

Our N2-[N2-(3-Hydroxy-9-Methyl-1-Oxodecyl)-D-Dab-]Cyclo[L-Dab*-L-Dab-D-Leu-L-Leu-L-Dab-L-Dab-L-Leu-] is produced and controlled under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research and development. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment. We can support development projects requiring compliance with cGMP, ICH Q7 guidelines, and other relevant pharmacopeial standards upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere packaging.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (MS)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Single Impurity (HPLC)	≤ 2.0%
Total Impurities (HPLC)	≤ 5.0%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Meets ICH limits

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.